EX-21 5 a38499exv21.htm EXHIBIT 21 exv21
 

EXHIBIT 21
SUBSIDIARIES OF THE REGISTRANT
          Valeant Pharmaceuticals International is incorporated in the State of Delaware. The following table shows the Company’s subsidiaries as of December 31, 2007, the percentage of their voting securities (including directors’ qualifying shares) then owned, directly or indirectly by the Company, and the jurisdiction under which each subsidiary is incorporated. These subsidiaries are included in the Company’s consolidated financial statements.
                 
         
        PERCENTAGE
        OF VOTING
    JURISDICTION   SECURITIES OWNED
    OF   BY COMPANY
    INCORPORATION   OR SUBSIDIARY
Valeant Argentina S.A.
  Argentina     100  
Laboratorios Valeant Argentina S.A.
  Argentina     100  
Valeant Pharmaceuticals Australasia Pty. Ltd.
  Australia     100  
Valeant Farmaceutica do Brasil Ltda.
  Brazil     100  
Valeant Canada Ltd.
  Canada     100  
Valeant Canada Holdings Ltd.
  Canada     100  
Valeant Pharma Hungary Commercial LLC
  Hungary     100  
Valeant Farmaceutica, S.A. de C.V.
  Mexico     100  
Laboratorios Grossman, S.A.
  Mexico     100  
Logistica Valeant S.A. de C.V.
  Mexico     100  
Valeant Biomedicals Dutch Holdings B.V.
  Netherlands     100  
Valeant Dutch Holdings B.V.
  Netherlands     100  
ICN Polfa Rzeszow S.A.
  Poland     99  
Valeant Global Pte. Ltd.
  Singapore     100  
Valeant Pharmaceuticals Singapore Pte. Ltd.
  Singapore     100  
Valeant Singapore Pte. Ltd.
  Singapore     100  
Valeant Pharmaceuticals Switzerland GmbH
  Switzerland     100  
Valeant Biomedicals, Inc.
  Delaware (USA)     100  
Valeant Pharmaceuticals North America
  Delaware (USA)     100  
 
               
 
*   In accordance with the instructions of Item 601 of Regulation S-K, certain subsidiaries are omitted from the foregoing table.